Psychological and Lifestyle Risk Factors for Asthma Exacerbations and Morbidity in Children
Overview
Affiliations
Asthma is the most common childhood illness and disproportionately affects low-income, minority children who live in urban areas. A range of risk factors are associated with asthma morbidity and mortality, such as treatment non-adherence, exposure to environmental triggers, low-income households, exposure to chronic stress, child psychological problems, parental stress, family functioning, obesity, physical inactivity, and unhealthy diets. These risk factors often have complex interactions and inter-relationships. Comprehensive studies that explore the inter-relationships of these factors in accounting for asthma morbidity and mortality are needed and would help to inform clinical intervention. Considerable research has focused on interventions to improve adherence, asthma management, asthma symptoms, and quality of life for patients with asthma. Educational interventions combined with psychosocial interventions, such as behavioral, cognitive-behavioral, or family interventions, are beneficial and provide care in schools, homes, and emergency rooms can help to address barriers to accessing care for children and families. Additional recent research has explored the use of multidisciplinary, collaborative, integrated care with pediatric asthma patients, providing promising results. Integrated care could be ideal for addressing the multitude of complex psychosocial and wellness factors that play a role in childhood asthma, for increasing patient-centered care, and for promoting collaborative patient-provider relationships. Further research in this area is essential and would be beneficial.
Du L, Che C, Liu Q, Zhang X, Feng N, Chen L BMC Pediatr. 2025; 25(1):180.
PMID: 40065274 PMC: 11895307. DOI: 10.1186/s12887-025-05552-5.
Association between omega-6 fatty acid intake and asthma in US children and adolescents.
Zhang X, Qu Y, Du L, Chen L, Luan H, Zhou H BMC Pediatr. 2024; 24(1):691.
PMID: 39478523 PMC: 11523806. DOI: 10.1186/s12887-024-05177-0.
Wang C, Wang L, Ding W, Zhao F, Hou G J Health Popul Nutr. 2024; 43(1):168.
PMID: 39449095 PMC: 11515328. DOI: 10.1186/s41043-024-00663-8.
The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections.
Sey E, Warris A Oxf Open Immunol. 2024; 5(1):iqae008.
PMID: 39193472 PMC: 11316619. DOI: 10.1093/oxfimm/iqae008.
Markus H, Ceneviva G, Thomas N, Krawiec C Pediatr Pulmonol. 2024; 59(12):3410-3418.
PMID: 39185635 PMC: 11601000. DOI: 10.1002/ppul.27219.